Georgia (Government of) Oct 08

  • ID: 1806930
  • October 2008
  • Region: Georgia
  • Standard & Poors
1 of 3


  • Georgia (Government of)
  • MORE

High potential growth rate The government's political commitment to prudent financial policies and market-oriented structural reforms Moderate levels of government debt Uncertainty arising from regional conflicts, as well as from developing political, legal, and economic institutions Weak external indicators aggravated by a difficult relationship with Russia Externally leveraged domestic banking system A narrow economic base Georgia's economy is stabilizing following the brief but intense war with Russia, and will be supported by an estimated $3 billion (24% of GDP) in foreign aid, which will help fund the sovereign's substantial external financing needs and rebuild damaged infrastructure. Estimated at $2,852 in 2008, per capita GDP is expected to continue rising supported by good long-term economic prospects. This, however, depends on the...

Companies mentioned in this report are: Georgia (Government of)
Action: Review

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

Georgia (Government of)

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.